These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6858829)

  • 1. Amrinone therapy in congestive cardiomyopathy.
    Reader C; Peyregne EA; Suárez LD
    Am Heart J; 1983 Jun; 105(6):1045. PubMed ID: 6858829
    [No Abstract]   [Full Text] [Related]  

  • 2. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ; Lvoff R; Chong B; Barrett PA
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amrinone, a new cardiotonic agent].
    Taira N
    Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.
    Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH
    Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340
    [No Abstract]   [Full Text] [Related]  

  • 7. Amrinone-mediated thrombocytopenia.
    Kinney EL; Ballard JO; Carlin B; Zelis R
    Scand J Haematol; 1983 Oct; 31(4):376-80. PubMed ID: 6622977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
    Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.
    Satoh K; Maruyama M; Taira N
    Jpn Heart J; 1982 Nov; 23(6):975-80. PubMed ID: 7161881
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
    Silverman BD; Merrill AJ; Gerber L
    Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
    Guimond JG; Matuschak GM; Meyers F; Keating D
    Chest; 1986 Aug; 90(2):302-4. PubMed ID: 3731911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 17. Echocardiographic evaluation of cardiovascular effects of amrinone.
    Modena MG; Benassi A; Mattioli G
    Clin Cardiol; 1984 Nov; 7(11):593-8. PubMed ID: 6499289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.